Remodelling hypoxic TNBC microenvironment restores antitumor efficacy of Vgamma9Vdelta2 T cell therapy. Jing Y, Wu Y, Hu Q, Wu W, et al. Br J Cancer 2025;133:365-380.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jing Y, Wu Y, Hu Q, Wu W, et al. Remodelling hypoxic TNBC microenvironment restores antitumor efficacy of Vgamma9Vdelta2 T cell therapy. Br J Cancer 2025;133:365-380.
PMID: 40437021